Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

14-1177 - Shao et al v. Beta Pharma, Inc. et al


Download Files

Metadata

Document in Context
14-1177 - Shao et al v. Beta Pharma, Inc. et al
January 26, 2016
PDF | More
RULING (see attached) denying Defendants' [Doc. 101] Motion to Quash Subpoenas and denying as moot Defendants' [Doc. 108] Motion for Scheduling of a Conference. Signed by Judge Charles S. Haight, Jr. on January 26, 2016. (Overbey, C.)
March 27, 2017
PDF | More
MEMORANDUM AND ORDER ON SUBJECT MATTER JURISDICTION (see attached) directing all parties to submit affidavits establishing their citizenship for federal diversity jurisdiction purposes on or before Friday, April 14, 2017. All case deadlines are stayed pending the Court's review of the affidavits. If, after reviewing the affidavits, the Court determines that it possesses subject matter jurisdiction, the action may proceed. Otherwise, in the absence of such jurisdiction, the Court will dismiss the action. Signed by Judge Charles S. Haight, Jr. on March 27, 2017. (Dorais, L.)
May 4, 2017
PDF | More
OMNIBUS RULING (see attached). The Court HOLDS that subject matter jurisdiction exists by reason of the complete diversity of the parties, resolving the Court's 156 Memorandum and Order on Subject Matter Jurisdiction, and reinstating and resolving the four pending motions earlier deferred: the Plaintiffs' 110 Motion to Enforce Subpoenas is GRANTED IN PART, as to tax returns and related documents for the years 2009 and subsequent, and DENIED IN PART, WITHOUT PREJUDICE, as to tax returns and related documents for years prior to 2009; the Defendants' 113 Motion for Clarification is DENIED; the Plaintiffs' 114 Motion for Reconsideration to Modify the Court's 109 Ruling is GRANTED; and the Defendants' 133 Motion to Dismiss is DENIED. This resolution lifts the stay placed on all case deadlines by the Court's 156 Memorandum and Order, and the most recent Scheduling Order is now reinstated. If Defendants wish to assert the attorney-client privilege to prevent disclosure of any documents otherwise falling within the referenced subpoenas, they must expressly make that claim and comply with the particulars of Fed. R. Civ. P. 26(b)(5)(A) and L. Civ. R. 26(e), not later than Friday, June 30, 2017. Signed by Judge Charles S. Haight, Jr. on May 4, 2017. (Pskowski, R.)
November 1, 2017
PDF | More
ORDER (see attached). Defendants' 168 Motion to Dismiss Plaintiff Song Lu's Claims in Part is DENIED. Signed by Judge Charles S. Haight, Jr. on November 1, 2017. (Pskowski, R.)
April 19, 2018
PDF | More
ORDER (see attached) regarding Plaintiffs' 193 Motion to Join Parties Defendant and Add Supplemental Pleadings to the Complaint. Leave to supplement the pleadings and join Beta Pharma (USA) Inc. as party defendant is GRANTED, IN PRINCIPLE. Filing of the Proposed Third Amended Complaint and formal joinder is DEFERRED, pending resolution of the jurisdictional issue identified by this Order. Plaintiffs are ordered to file a brief regarding the jurisdictional basis for the proposed joinder of Beta Pharma (Hong Kong) Holding Company Ltd. as party defendant, on or before Thursday, May 3, 2018. Signed by Judge Charles S. Haight, Jr. on April 19, 2018. (Pskowski, R.)
April 19, 2018
PDF | More
ORDER (see attached) regarding Plaintiffs' 200 Letter Motion/Request for In-Camera Review Pursuant to Protective Order, dated April 12, 2018. Permission to submit the confidential documents referenced by this Letter Motion is GRANTED. Plaintiffs must file any supplemental memo in support of their 196 Motion for Modification of Protective Order on or before Thursday, May 3, 2018. Defendants may file opposing papers to that Motion, if so advised, no later than Monday, May 14, 2018, and Plaintiffs may file a reply, if any, no later than Monday, May 21, 2018. Signed by Judge Charles S. Haight, Jr. on April 19, 2018. (Pskowski, R.)